RamaZottius Lab

RamaZottius Lab is a Lithuanian medtech startup specializing in the development of innovative solutions for periodontal disease. The company's flagship product, Periozip, is a specialized gel featuring an advanced smart biomaterial of natural plant origin. Designed for application via a prefilled syringe directly into periodontal pockets, the product aims to harden within the cavity to inhibit the viability of disease-causing microorganisms. By providing a non-invasive alternative to traditional surgical interventions, the technology seeks to facilitate the repair of periodontal tissues while reducing the need for antibiotics and associated surgical risks.

Since its founding in 2020, the company has combined pharmaceutical biotechnology expertise with entrepreneurial leadership to address clinical needs in dental health. Supported by various European health innovation grants and clinical trials, the company is focused on securing CE certification for Periozip as a Class IIa medical device and scaling its commercialization through licensing and strategic partnerships. RamaZottius Lab aims to improve patient outcomes by offering safer, non-invasive treatment options that protect gums and prevent tooth loss, positioning itself within the deep-tech ecosystem to expand its international reach.